Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RAF-MEK-ERK pathway inhibitors to treat cancer

RAF-MEK-ERK pathway inhibitors to treat cancer

US Patent 7307071 · Granted Dec 11, 2007

Estimated economic value: $80,939,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of isoindolinone derivatives with SGI-1102022
Kinase modulation, and indications therefor2018
Kinase modulation, and indications therefor2017
Kinase modulation, and indications therefor2017
Kinase modulation and indications therefor2017
Hydrobenzamide derivatives as inhibitors of Hsp902016
Kinase modulation, and indications therefor2016
Pharmaceutical combinations2014
Pharmaceutical combinations2014
Pharmaceutical compounds2014
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase mo2013
Compounds and methods for kinase modulation, and indications therefor2013